Florida shuts monoclonal antibody treatment sites after FDA sets new limits

The Florida Department of Health announced that it is closing all monoclonal antibody treatment sites in the state after the U.S. Food and Drug Administration rescinded emergency-use authorizations for two particular treatments for COVID-19.
Go to Source